Mercia Pharma

Mercia Pharma is a biotech company that develops disease-specific immunotherapeutic products. Its MERIT technology platform enables the production of therapeutic and prophylactic vaccines focusing on autoimmune, chronic, and infectious diseases. The company provides products designed to stimulate antigen-specific protective immune responses, including antigen-specific regulatory T-cells, without provoking tissue destructive and cell-mediated inflammatory side effects.